// App-Quantinova.ai

: Phase I/Ib study of enzalutamide and gemcitabine and cisplatin in bladder cancer.

Researchers

Presenter

  • Shilpa Gupta

Principal Investigators

  • Mayer N. Fishman

  • Jasreman Dhillon

  • Anthony Martin Magliocco

  • John Puskas

  • Gisela Caceres

  • Taymeyah E Al-Toubah

  • Badrinath R. Konety

  • Matthew Lindemam

  • Gautam Gopalji Jha

  • Jingsong Zhang

Medical Centers

  • University of Minnesota, Minneapolis, MN

  • Moffitt Cancer Center, Tampa, FL

  • Anatomic Pathology, Moffitt Cancer Center, Tampa, FL

  • H. Lee Moffitt Cancer Center & Research Institute, Riverview, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Phosphorylated-AKT

  • Circulating tumor cells

Drug/Treatment

  • Enzalutamide

  • Gemcitabine

  • Cisplatin

Outcome

  • N/A

Study Design

  • Dose Escalation

Phase

  • NA

Study Id's

  • NCT02300610

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved